Dr Gareth Parkes

Consultant Gastroenterologist

BA, MA, MBBS, PhD, MRCP

Personal profile

Education 

  • Queens’ College Cambridge BA, MA
  • Bart’s and the London Medical School - MBBS with distinction
  • King’s College London - PhD - The role of the gastrointestinal bacteria in the development of irritable bowel syndrome 
Health Matters Consultant Contributor

Interests 

Inflammatory Bowel Disease 

I have had experience in three major centres in inflammatory bowel disease and now am part of a team of IBD specialists at the Royal London. I have published in this area and I am actively involved with clinical trials of novel biological therapies. I have experience in specialist IBD endoscopy, novel biologic agents and complex IBD patients. 

Irritable Bowel Syndrome 

I have an active interest in irritable bowel syndrome or IBS, in particular in the role that diet and the gut microbiota play in the causes and treatment for this condition. I have published widely in this field in particular in the role that probiotic preparations can have in the treatment of IBS. 

Endoscopy 

I have broad range of endoscopic experience and I am competent in a wide range of diagnostic and therapeutic procedures including in the diagnosis of cancer, ulcers, Barrett’s oesophagus, colitis, Crohn’s disease, diverticular disease and polyps. In particular I specialise in difficult colonoscopy and polypectomy as well as working as a trainer within the NHS. 

Publications 

  • Parkes GC, Whelan K, Lindsay JO.Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns and Colitis 2014 Aug 1;8(8):717-25
  • Parkes GC, Rayment NB, Hudspith BN, Petrovska L, Lomer M, Brostoff J, Whelan K, Sanderson JD. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol Motil. 2012 Jan;24(1):31-9
  • Parkes GC, Sanderson JD, Whelan K. Treating irritable bowel syndrome with probiotics: the evidence. Proc Nutr Soc. 2010 May;69(2):187-94. 2010 Mar 18.
  • Parkes GC, Sanderson JD, & Whelan, K. The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea. Lancet Infect Dis 2009;9:237-244
  • Parkes GC, Brostoff, J., Whelan, K. & Sanderson, JD. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment Am J Gastroenterol.2008; 103:1557-1567 
  • Lomer MC, Parkes GC, Sanderson JD. Review article: lactose intolerance in clinical practice--myths and realities. Aliment Pharmacol Ther 2008;27(2):93-103.

Professional Membership

  • British Society of Gastroenterology
  • European Crohn’s and Colitis Organisation
  • Royal College of Physicians

Clinical Interests

  • Inflammatory bowel disease 
  • Irritable bowel syndrome including the use of probiotics and dietary therapy 
  • Gastro-oesophageal reflux disease 
  • Indigestion 
  • Coeliac disease
  • Bowel cancer 
  • Colonic polyps 
  • Abnormal liver function

Request an appointment

Please complete the form below, making sure you provide us with as much detail as possible. We aim to answer all enquiries within 24 hours, but due to high volume we sometimes might not be able to do so.

*Required field.

Title *
First Name *
Last Name *
Email Address *
Daytime tel *
Postcode *
Consultant
Hospital *
Treatment
Type of enquiry
How would you prefer to fund your treatment? *
Please use this box to tell us more about your enquiry
(Max 500 characters)

500 Characters remaining

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.